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Summary 
 
‘Avoidable’ mortality has been proposed as a measure of performance of the 
health system and as a measure of quality of health care service delivery. 
Several researchers have updated the concept, defining ‘avoidable’ mortality as 
deaths from causes that should not occur in the presence of timely and effective 
interventions. This offers a means of understanding the effectiveness of health 
systems in maintaining and improving population health. This indicator can be 
disaggregated into treatable and preventable mortality providing policy relevant 
information on the performance or quality of the health care system in detecting 
and treating selected conditions, and the success of broader health policy in 
preventing disease and promoting health.   
 
This methodological note reviews the existing evidence and elaborates the 
definition and construction of the ‘avoidable’ mortality indicator (e.g. selection of 
causes of death and age limits) as set out in the literature, including a summary 
of the available empirical evidence. While the concept of ‘avoidable’ mortality 
has advantages, it also has some the limitations that will be discussed further. 
In particular, there are challenges in undertaking cross-country comparisons. 
The benefits of this approach will be considered together with the methodological 
challenges involved. 
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I. Introduction  
Quality of care and health system performance are complex concepts with numerous 
dimensions. Research over recent decades points to the fact that definitions of quality 
vary widely and there is not one indicator which can be used alone to reflect the 
performance of any system. Indicators may capture different aspects of the structure of 
the system, its processes or ultimately, the outcomes – the three approaches that can 
be taken to evaluate the health system, as proposed  by Donabedian in the 1970s 
(Donabedian, 2005 reprint of Donabedian`, 1966). The measure of ‘avoidable’1 mortality 
is one of many outcome indicators which can be used to evaluate the performance of the 
health system.  
 
The application of the concept of ‘avoidability’ dates back to at least the early 20th 
century when, in the United Kingdom, in 1928 confidential enquiries were made into 
maternal deaths to first identify errors and areas where improvements could be made to 
avoid unnecessary deaths (Holland, 2009); in the United States similar enquiries were 
carried out in the early 1930s and also led to important reductions in maternal mortality 
rates (New York Academy of Medicine. Committee on Public Health Relations, 1933).  
The World Health Organization in a report describing the methods of investigation of 
maternal mortality and morbidity stated that while there is no formal proof of the 
effectiveness of such enquiries ‘the lessons derived will enable health care practitioners 
and health planners to learn from the past’ (Holland, 2009; World Health Organization, 
2004).  
 
The concept of ‘avoidable’ deaths was proposed by Rutstein and colleagues in 1976 
(Rutstein et al., 1976). The group outlined the method of measuring the quality of 
medical care2 that counts cases of unnecessary disease, disability and untimely deaths. 
Rutstein and colleagues (1976) defined medical care in its broadest sense as “the 
application of all relevant medical knowledge, the basic and applied research to increase 
that knowledge and make it more precise, the services of all medical and allied health 
personnel, institutions and laboratories, the resources of governmental, voluntary and 
social agencies, and the co-operative responsibilities of the individual himself”. 
 
                                                            
1 The literature on ‘avoidable’ mortality variously uses the terms ‘avoidable mortality’, ‘amenable mortality’, 
‘treatable mortality’ or ‘preventable mortality’. It is beyond the scope of the note to discuss the reasoning 
behind this variation in terminology (see Nolte and McKee 2004 for further discussion). While recognising the 
differences between these terms, for simplicity we here use the term ‘avoidable’ throughout.   
2 Rutstein and colleagues (1976) defined “quality” as the effect of care on the health of the individual and of 
the population (outcome). Improvement in the quality of care should be reflected in better health.  
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Their list included around 90 conditions which they considered as sentinel health events. 
When selecting the conditions, they “assumed that if everything had gone well, the 
condition would have been prevented or managed”.  As Rutstein and colleagues 
acknowledged, “the chain of responsibility to prevent the occurrence of any unnecessary 
disease, disability, or untimely death may be long and complex; the failure of any single 
link may precipitate an unnecessary undesirable health event.” As a result, often it may 
be difficult to establish who is responsible. For example, they cited deaths from 
diphtheria, measles and poliomyelitis for which the responsibility may lie in the state 
which may not have provided the necessary funding, the health officer who did not 
implement the program, the medical society that opposed community clinics, physician 
who did not immunize the patient, the religious views of the family, or the mother who 
did not care to bring her child for immunization (Rutstein et al., 1976). However, they 
thought that in each death considered unnecessary and untimely the physician has the 
“initial and also some continuing responsibility”. Similar examples can be derived for 
many other conditions.  
 
It was Rutstein’s work that provided the basis for the concept and was followed by 
numerous publications which applied the concept empirically, reviewed the list of 
conditions, adjusted the definition of medical care and its scope, as well as the age 
limits. These will be described in this methodology note together with the most 
important issues relevant for the application of the indicator in the European Union 
countries. The note draws on the extensive review prepared by Nolte and McKee (2004) 
and summarizes some of its main findings.  
 
First, the history of the concept will be discussed, followed by a summary of the 
empirical evidence to see how the measure has been applied to date. It will then discuss 
the limitations of the measure.  Finally, implications for using the measure on an 
aggregate level for monitoring and comparing health systems in the European Union will 
be discussed and recommendations will be made.   
 
II. The Concept 
After the initial work carried out on maternal mortality in the early 20th century, and 
Rutstein and colleagues’ extension of the concept of ‘avoidable’ mortality in 1976, the 
concept and application of the indicator continued to be expanded (Table 1).  
Interestingly there was no attempt to use Rutstein’s methodology in the United States 
(Holland, 2009). Charlton and colleagues (Charlton, Hartley, Silver, & Holland, 1983) in 
the United Kingdom narrowed the concept by excluding conditions which were 
considered to be outside the scope of medical care, e.g. road traffic accidents, tobacco 
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policy. They were the first to apply ‘avoidable’ mortality empirically at the population 
level and to examine national and international trends (Nolte & McKee, 2004), as well as 
the importance of disease incidence and social factors. At the same time they introduced 
an upper age limit for some conditions at 65 years.  
 
In 1986 a major project was undertaken in the European Community which resulted in 
the publication European Community Atlas of ‘Avoidable Death’  under the EC Concerted 
Action Project on Health Services and  ‘Avoidable Deaths’ (Holland, 1988, 1991, 1993, 
1997).  This project extended the work of Charlton and colleagues (1983) and used a 
definition of health services, which were interpreted to include primary care, hospital 
care and collective health services such as screening and public health services, e.g. 
immunisation. The original list also included conditions whose control mainly depended 
on primary prevention or health policies, which were outside the direct control of health 
services, e.g. lung cancer, liver cirrhosis or motor vehicle accidents; these were excluded 
from the most recent edition (Nolte & McKee, 2004).  
 
Table 1. Development of the concept of ‘avoidable’ mortality 
Authors Definition of 
Health 
Services 
Number of 
conditions 
Contribution Upper 
age Limit 
Rutstein et 
al. 
1976  
Includes 
“application of 
all relevant 
medical 
knowledge, 
the basic and 
applied 
research to 
increase that 
knowledge 
and make it 
more precise, 
the services of 
all medical 
and allied 
health 
personnel, 
institutions 
and 
laboratories, 
the resources 
of 
governmental, 
voluntary, and 
social 
agencies, and 
the co-
Over 90 
conditions 
as ‘sentinel 
health 
events’ 
 
Conditions divided into: 
i) even a single death 
justifies immediate enquiry 
(split to 
preventable/treatable) 
ii) not every single case is 
preventable or manageable 
but where appropriate care 
should be associated with 
lower incidence of that 
condition (split to 
preventable/treatable) 
Stresses that for each 
unnecessary untimely 
death the physician has the 
initial and some continuing 
responsibility.  
None 
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Authors Definition of 
Health 
Services 
Number of 
conditions 
Contribution Upper 
age Limit 
operative 
responsibilities 
of the 
individual 
himself” 
Charlton et 
al. 
1983 
Excludes 
conditions 
which 
considered to 
be outside the 
scope of 
medical care 
(primary care, 
hospital care, 
public health 
programmes) 
 
14 disease 
groups  
First to apply concept 
empirically at the 
population level to analyse 
area variation in mortality 
in England & Wales (1974-
78)  
Examines national and 
international trends 
between 1956 and 1978.  
65 for 
some 
conditions 
and less 
for others  
Poikolainen 
and Eskola  
1986,1988 
Excludes 
conditions 
which 
depended 
mainly on 
efforts outside 
the health 
services (e.g. 
lung cancer)  
Extend by 
more than 
70 
amenable 
and 20 
partly-
amenable 
conditions 
Analyse trends in Finland 
between 1969 - 1981 
Drew up explicit list of “not 
amenable” conditions 
Age limit 
set for all 
conditions;
 
65 for 
some 
conditions 
and less 
for others 
European 
Community 
Atlas  
(Holland) 
1988/91; 
1993; 1997 
 
Health care 
services 
include 
primary care, 
hospital care 
and collective 
health services 
such as 
screening and 
public health 
programmes, 
e.g. 
immunisation. 
 
Initially also 
includes 
conditions 
whose control 
depends on 
primary 
prevention 
(health) 
policies with 
action outside 
the direct 
control of 
1st 
edition/1st 
volume of 
2nd edition: 
17 disease 
groups  
 
2nd volume/ 
2nd edition: 
expands by 
8 conditions 
where role 
of health 
services in 
the 
reduction of 
mortality 
less certain  
 
3rd edition:  
combination 
of causes 
from 
previous 
editions 
(total of 16)
Conditions that “provide 
warning signals of potential 
shortcomings in health care 
delivery” and conditions for 
which at least a proportion 
of deaths can be prevented.  
Stimulated a range of 
country –specific studies. 
Apply a range of causes of 
deaths. 
 
Age limit 
set for all 
conditions; 
 
In the last 
edition:   
65 for 
some 
conditions 
and less 
for others 
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Authors Definition of 
Health 
Services 
Number of 
conditions 
Contribution Upper 
age Limit 
health 
services; 
these were 
later excluded.  
 
Mackenbach, 
1980s 
Used a more 
restricted 
definition of 
medical care 
as “the 
application of 
biomedical 
knowledge 
through a 
personal 
service 
system”;  
exclude 
conditions for 
which effective 
intervention is 
outside the 
direct control 
of medical 
care system, 
including 
many forms of 
primary 
prevention 
  
Based on 
EC project  
Link trends in mortality to 
specific innovations in 
medical care 
 
Could not 
identify 
clear 
evidence 
for age 
limits 
except for 
a few 
conditions 
Westerling, 
1992, 1993 
& 1996 
Indicators 
reflecting the 
outcome of 
medical care 
and those 
mainly 
reflecting the 
effect of 
national health 
policy 
Based on 
Rutstein 
and EC  
project 
First explicit comparison of 
"preventable conditions” vs 
“treatable conditions” and 
empirical application  
65  
Simonato, 
1998 
Primary 
prevention, 
reduction of 
exposures 
(includes 
measures 
outside the 
health 
services); 
secondary 
prevention, 
early detection 
Based on 
Rutstein, 
Charlton 
and EC 
project and 
additional 
new causes 
Presents the following 
differentiation:  
1) amenable to primary 
prevention 2) amenable to 
early detection and 
treatment  
3) amenable to improved 
treatment and medical care 
65  
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Authors Definition of 
Health 
Services 
Number of 
conditions 
Contribution Upper 
age Limit 
and 
treatment; 
and tertiary 
prevention, 
improvement 
in treatment 
and medical 
care 
Tobias and 
Jackson, 
2001 
The concept of 
avoidability 
was extended 
to cover not 
only causes of 
death 
amenable to 
therapeutic 
intervention 
but also those 
responsive to 
individual and 
population-
based 
preventive 
interventions 
 
56 
conditions 
Broadened 
list of 
conditions 
by 
reviewing 
literature of 
advances in 
health care 
since 1980s 
Distinguishes 3 categories: 
(primary/secondary/tertiary 
prevention) with relative 
weights for each derived 
through expert consensus.  
 
Substantially broadened list 
of potentially “‘avoidable’” 
conditions. 
 
75 
Nolte & 
McKee, 2004 
Health care 
services 
include 
primary care, 
hospital care 
and collective 
health services 
such as 
screening and 
public health 
programmes, 
e.g. 
immunisation. 
34 
conditions  
Based on 
Charlton et 
al., Tobias 
and 
Jackson, 
Mackenbach
Updates list based on most 
recent advances in medical 
knowledge and technology 
 
Conditions selected 
considered indicators of the 
impact of health care 
75 
Source: Based on (Nolte & McKee, 2004 and Charlton et al., 1983; Holland, 1997; 
Poikolainen & Eskola, 1988; Simonato, Ballard, Bellini, & Winkelmann, 1998; Tobias & 
Jackson, 2001; Westerling, 1993) 
 
Several country specific analyses resulted from the EC Atlas carried out by participating 
researchers, as well as in non-participating countries (Nolte & McKee, 2004).  However, 
studies used different lists of ‘avoidable’ conditions, with varying age limits and methods 
of analysis. Lack of suitable data or insufficient numbers of deaths for some of the 
conditions may explain the differences in the methods applied (Mackenbach, Bouvier-
Colle, & Jougla, 1990). In the 1980s Mackenbach and colleagues analysed the possible 
contribution of medical care innovations to mortality changes by analysing trends in 
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mortality from selected conditions and found that “although the exact contribution of 
medical care innovations to changes in mortality cannot be determined, the impact of 
medical care on post-1950 mortality in the Netherlands could well have been 
substantial” (Mackenbach, Looman, Kunst, Habbema, & van der Maas, 1988). They used 
a stricter definition of medical care defining it as “the application of biomedical 
knowledge through a personal service system” building on Rutstein’s list of conditions.   
 
Further work has focused explicitly on differentiating and comparing levels of ‘avoidable’ 
mortality attributable to the health care system and to wider health policies usually not 
within the direct control of health services. While this distinction had been made in 
earlier publications (Holland, 1986; Rutstein et al., 1976), this time conditions were 
clearly split as indicators for the different areas of health care (Westerling, 1993; 
Westerling, Gullberg, & Rosén, 1996; Westerling & Smedby, 1992).  Tobias and Jackson 
(2001), following an expert consensus exercise in New Zealand, partitioned  the relative 
avoidability of death from conditions into proportions which are avoidable by primary, 
secondary, and tertiary actions (Tobias & Jackson, 2001). For example, avoidability of 
deaths from asthma was partitioned into primary, secondary and tertiary interventions 
with weights 0.1, 0.7, and 0.2, respectively, while tuberculosis received weights of 0.6, 
0.35 and 0.05, respectively. According to this approach, death from tuberculosis is 
considered, largely, avoidable by primary prevention while death from asthma is 
primarily avoidable by secondary prevention through early detection and treatment. 
However, the usefulness of broader concept is limited because it is mainly to “measure 
the theoretical scope for further population health gain, not what may be considered 
feasible given current technology, available resources and competing values” (Nolte & 
McKee, 2004).  Finally, the work of Nolte & McKee (2004) looked at ‘avoidable’ mortality 
and changing life expectancy in the European Union in the 1980s and 1990s using an 
updated list of conditions taking into consideration advances in medical knowledge and 
technology.  
 
III. Empirical Evidence 
As shown by Nolte and McKee (2004) numerous studies have applied the concept of 
‘avoidable’ mortality empirically. As noted above, these studies vary in the selection of 
conditions deaths of which are considered avoidable by health care, definitions of 
medical care and/or health services and age limits so limiting comparability of findings 
(Nolte & McKee, 2004). While some only looked at trends in ‘avoidable’ mortality others 
attempted to identify factors that might explain these trends or any variations. Given 
that the indicator is assumed to measure the effectiveness of health services, it might be 
expected that variations in ‘avoidable’ deaths could be linked to health care inputs; 
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however, of those studies that did attempt to establish such link, most tended to capture 
only quantity but not the quality of health services and, perhaps unsurprisingly, could 
not establish a clear association between health care input and (population) health 
outcome. Nolte and McKee (2004) reviewed over 70 studies and grouped them into 
three categories as follows: 
 
• Studies that examine the variation geographically. These suggest that there is 
little association between geographical variation in ‘avoidable’ mortality and 
differences in quality or quantity of health services, as measured by routine data; 
geographical variations seem to be more closely related to socioeconomic 
conditions. 
• Studies that examine variation between social groups. These suggest that 
population groups classified as being at social disadvantage because of ethnicity 
or socioeconomic characteristics tend to be at higher risk of death from 
‘avoidable’ conditions. 
• Studies that examine variation in ‘avoidable’ mortality over time. These tend to 
show consistent declines in ‘avoidable’ mortality that have been more rapid than 
declines in mortality from causes not considered ‘avoidable’. 
 
IV. Limitations of the concept of ‘avoidable’ mortality 
Nolte and McKee (2004) have highlighted several limitations of the concept of ‘avoidable’ 
mortality that require attention if it is to be used for measuring the effectiveness of 
health services. Understanding these limitations is important, especially if the measure is 
to be routinely utilized at the European level.  
 
• The association between ‘avoidable’ mortality and health care inputs 
‘Avoidable’ mortality was originally intended to assess the quality of care (Holland & 
Breeze, 1985) but has also been used to measure the contribution of health systems to 
population health. Many authors have attempted to explain observed variations in 
‘avoidable’ mortality using a range of potential explanatory variables of which health 
care resources has been one. However, given the weak association between variations in 
‘avoidable’ mortality and measures of health care provision (Kunst et al., 1988; 
Mackenbach, Kunst, Looman, Habbema, & van der Maas, 1988), some authors have 
questioned the usefulness of this indicator to measure the quality and effectiveness of 
health care services (Carr-Hill, Hardman, & Russell, 1987). It is important to clarify that 
most of the variables studied to explain variations in ‘avoidable’ deaths such as health 
expenditure, number of health staff or hospital beds, presence of health care facilities 
tend to  only capture quantity but not quality of care (Nolte & McKee, 2004).  At the 
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same time, evidence from analyses undertaken in the former communist countries of 
central and eastern Europe (Koupilová, McKee, & Holcik, 1998; Nolte, Scholz, 
Shkolnikov, & McKee, 2002; Telishevska, Chenet, & McKee, 2001; Velkova, 
Wolleswinkel-van den Bosch, & Mackenbach, 1997) supports the link between health 
care resources and outcomes as measured by mortality. Overall, the weak or absent 
association with health care inputs may be attributable to (i) the use of variables which 
are measurable but not necessarily important; and/or ii) a time lag between changes in 
resources and changes in mortality and others (Nolte & McKee, 2004).  However, the 
more frequently observed association with adverse socioeconomic factors has focused 
attention to timely access to medical care (Nolte & McKee, 2004).  
 
• Interpreting trends in ‘avoidable’ deaths over time 
When interpreting observed trends in ‘avoidable’ mortality over time it is necessary to 
take account of a number of factors. Changing mortality from a given condition 
considered ‘avoidable’ might be due to changes in the incidence of the disease which can 
result from changes in behavioural and environmental risk factors. Therefore, it is 
important to understand the course of particular conditions and changes in medical 
interventions to be able to attribute changes in mortality to medical care.  
 
• Selection of ‘avoidable’’ conditions and the attribution of health 
outcomes 
The selection of conditions in which death should be considered ‘avoidable’ by 
appropriate health care has differed by study and may have been determined by data 
availability, definition of medical care and whether a given condition is considered to be 
preventable or treatable. Some have questioned the inclusion of some ‘avoidable’ 
conditions as performance indicators of health services (Walsworth-Bell & Allen, 1988). 
Yet it is important to note that when the concept was first applied by Charlton, they 
stressed that aggregate analyses are insufficient and “do not provide definitive evidence 
that a particular services is wrong” (Holland & Breeze, 1985). Rather, findings should be 
seen as giving a first indication that there may be a problem in the health care system 
and it should be further investigated. Attributing health outcomes solely to health care 
services will only be possible for some conditions. Yet for many others mortality will 
result from the combination of environmental, nutritional, genetic and social factors, as 
well as health services. These have to be investigated.  
 
• The changing concept of avoidability 
As mentioned earlier, many studies apply some version of the original Rutstein list of 
conditions, Charlton’s or the conditions selected for the EC Project.  However, given the 
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advances that have been made in medical care, it is likely that there are now additional 
conditions that may be considered to be ‘avoidable’ as effective prevention or treatment 
has become available. At the same time, some conditions which have been used earlier 
may no longer be a good indicator. Therefore, depending for which period the analysis is 
being carried out, the changing concept of avoidability must be taken into consideration, 
since advances in medical care should continuously be considered.  
 
• Contribution of ‘avoidable’ conditions to overall mortality  
In some countries deaths from certain ‘avoidable’ conditions occur rarely. Therefore, 
deriving conclusions about the quality of health care based on small numbers was not 
considered entirely appropriate (Westerling & Smedby, 1992). Yet today when age limits 
have been raised to reflect rising life expectancies, this criticism may no longer apply 
(Nolte & McKee, 2004).   
 
• Underlying disease incidence and disease severity at presentation 
In general, the extent to which health care services can help the patient depends on the 
severity of symptoms he or she presents with; patients may present too late because of 
factors affecting their health seeking behaviour. Disease incidence may explain a large 
proportion of regional or national variations in mortality and might be taken into 
consideration, even though this is often not possible due to lack of data. However, it can 
be argued that incidence is irrelevant, since services should be planned to take “need” 
into account – thus areas or populations with greater frequency of the disease studied 
should have more provision than areas/populations with a lower frequency (Charlton et 
al., 1983).  As Charlton and colleagues note (Charlton, Holland, Lakhani, & Paul, 1987), 
“there is no reason for more deaths to occur from conditions such as acute appendicitis 
or hernia in areas where the condition may be more common”. 
 
• Cause of death certification and coding 
Nolte & McKee (2004) note that, in any analysis that uses cause of death data, 
differences between countries on the indicator of ‘avoidable’ mortality may be, at least in 
part, because of differences in diagnostic patterns, death certification and coding of 
causes of death (Kelson & Farebrother, 1987). Also, assigning a single underlying cause 
of death for a person who has been suffering from multiple chronic conditions, 
particularly among older people, is often difficult and subject to variation even if the 
rules of certification and coding are well-understood and clearly formulated. Mortality 
data is also likely to underestimate the burden of disease for low-fatality conditions such 
as diabetes or other chronic disorders (Jougla et al., 1992; Ruzicka & Lopez, 1990). 
Thus, interpreting mortality statistics requires careful consideration of their limitations, 
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and where possible, efforts should be made to improve their quality (Charlton in 
Hansluwka, Lopez, Porapakkham, & Prasartkul, 1986). This is particularly true for cross-
country comparisons and caution must be exercised in the interpretation of results and 
conclusions.  
 
• Focus on mortality 
It is important to acknowledge that focusing only on mortality may not always be the 
most appropriate indicator for measuring the effectiveness of the health care system 
(Holland & Breeze, 1985). Especially, because health care also has non-health outcomes 
such as its impact on the general wellbeing of the society or alleviation of the risk of 
impoverishment as a consequence of the disease (Buck, Eastwood, & Smith, 1999). 
Activities which focus on relieving pain or improving quality of life will also not be 
captured by this measure (Holland & Breeze, 1985).  
 
• Negative consequence of medical care 
Finally, most studies of ‘avoidable’ mortality have not addressed the potential negative 
impact of medical care. Iatrogenesis or medical errors, negligence and adverse effects 
have only recently become the focus of policy makers’ attention (Nolte & McKee, 2004). 
Estimates for the United States suggest that up to 98,000 deaths annually may result 
from medical errors (Kohn, Corrigan, & Donaldson, 1999). In the United Kingdom, since 
2001 the National Patient Safety Agency also monitors information about incidents which 
may have led to harming a patient or even death.  However, incidents continue to be 
under-reported because the reporting and feedback environment is still one of “naming 
and shaming” (Cassidy, 2009; Health Committee, 2009; Healthcare Commission, 2008).  
 
 
V. Issues to consider and recommendations 
Given the existing evidence and the limitations, using ‘avoidable’ mortality as an 
indicator of population health at the EU level should be undertaken with a careful 
consideration of how it is used, by whom and for what purpose. To date the indicator 
was intended to point towards areas which require further investigation into health 
service provision and not as an absolute measure of outcome. However, aside from the 
systematic literature review undertaken by Nolte and McKee (2004) that also included an 
attempt to establish an ‘up to date’ list of conditions that may be considered ‘avoidable’ 
in the presence of timely and effective contemporary care, fairly little work has been 
done to advance the original concept of individual enquiries into preventable deaths and 
most studies are examples of descriptive epidemiology. Rutstein et al. (1976) noted that 
“the search for underlying preventive or therapeutic inadequacies is an essential step in 
 13
the complete application of the method”. This involves, as a first step, the aggregate 
analysis of trends; and second should involve the identification of underlying causes and 
appropriate follow up.  
 
Identifying the causes of death to be considered ‘avoidable’ by timely and 
effective health care 
Apart from maternal and perinatal mortality, there are few examples of systematic 
investigation, at local or national level, to identify the possible causes of failure of health 
care and what can be done to improve outcomes (Holland, 2003). It is this type of follow 
up that should be encouraged in the EU countries. To date, when data was used to 
improve services, it often resulted in identifying and a culture of blaming the individual 
practitioner rather than considering system deficiencies; other ‘side-effects’ tend to 
include inappropriate policy responses, lack of resources, lack of coordination of care as 
well as individual errors (Holland, 2009).   
 
For these reasons, it is highly recommended that systematic investigations of ‘avoidable’ 
deaths are carried out, following existing and sound methodologies. Methods of enquiry 
have been proposed for maternal mortality and summarized in the 2004 World Health 
Organization Report (World Health Organization, 2004). The WHO Report (2004) 
provides a range of approaches the applicability of which depends on the level of 
investigation, i.e. facility, community, district, regional or national level (Table 2).   
TABLE 2: Methods of enquiries at the different levels 
Level Outcome - ‘Avoidable’ Death 
(maternal mortality or other)  
Community Verbal autopsy 
(community based death reviews) 
Facility or groups of facilities Facility based death review 
District/regional/national Confidential enquiry into death 
Source: Adopted from WHO (2004)  
 
Confidential enquiries are most appropriately undertaken at the local level. They 
comprise a systematic multi-disciplinary anonymous investigation of all or a 
representative sample of deaths occurring at an area, district, regional or national level; 
they aim to identify the numbers, causes and avoidable or remediable factors associated 
with deaths so identified (Lewis, 2003). Through lessons learned from each death and 
through aggregating the data, they provide evidence of where the main problems lie and 
what can be done in practical terms. Thus, confidential enquiries have the potential to 
 14
highlight the key areas requiring recommendations for health sector and community 
action and can so guide the improvement of clinical outcomes (World Health 
Organization, 2004). Certainly, it will not be possible to prevent all deaths for a given 
condition considered ‘avoidable’ but confidential enquiries are likely to provide detailed 
information on the extent of deaths that have occurred because of weaknesses or 
failures of the relevant system and so point to appropriate interventions to improve the 
quality of care and reduce such deaths in the future.   
 
 
Selection of conditions 
The selection of conditions to be considered ‘avoidable’ and monitored will depend on the 
definition and scope of health services which are to be evaluated and by which 
stakeholder. The definition can include public health policies (e.g. tobacco control, road 
safety, and alcohol policies), activities of health authorities as well as activities directly 
attributable to medical treatment at the primary, secondary and tertiary level. 
Conversely, the definition of health services can be more restrictive, including only those 
activities which are directly attributable to health care providers (primary, specialist and 
hospital care) and collective health services such as immunisation and screening. Such a 
definition would thus not include conditions whose ‘avoidability’ is more closely related to 
wider intersectoral policies such as traffic injuries.  
 
At present the “AMIEHS” project - Avoidable mortality in the European Union: towards 
better indicators for the effectiveness of health systems – aims to develop an agreed 
definition of ‘avoidable’ mortality for Europe, and to derive a set of validated ‘avoidable’ 
mortality-based indicators of the effectiveness of health systems which can be used in 
routine surveillance systems. A systematic review of the literature to assess the extent 
to which different causes of death can now be considered ‘avoidable’ by preventive and 
curative health care interventions is being carried out.  As part of the project, it will be 
verified whether the introduction of medical innovations coincided with measurable 
declines in mortality in seven European countries, using in-depth information on the 
introduction of each innovation in these countries, and taking into account possible data 
artefacts caused by successive revisions of ICD codes. Based on these findings, a group 
of experts will be consulted on the conditions which should be considered as valid 
‘avoidable’ mortality indicators.  The project also includes an examination of appropriate 
age ranges for each condition.  
 
The findings of this project will form a great contribution in terms of systematizing the 
evidence on the preventability or treatability of conditions considered ‘avoidable’ 
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although it is likely that the causes originally selected already more than 20 years ago in 
the context for the EC ‘Atlas on Avoidable Deaths’ mentioned earlier are likely to form a 
key component of ‘avoidable’ conditions, such as tuberculosis. It is important to note 
that deaths for many of these conditions, although, in theory, ‘avoidable’, are likely to 
continue occurring in EU countries because of variation in the use and implementation of 
the existing medical knowledge or the organization of the health systems among 
countries. Overall, unnecessary deaths are likely to result from untimely diagnosis, 
inappropriate treatment, lack of coordination or communication among different levels of 
care, inefficient distribution of resources or other aspects of health care provision not 
measurable unless case by case systematic enquires are undertaken into the causes of 
deaths on the country level.  
 
Data issues 
Mortality data is routinely collected in all the European Union countries. However, in 
order to be able to monitor ‘avoidable’ death rates and make international comparisons, 
detailed data on mortality by ICD codes on the regional level needs to be made 
available. Standardisation of data collection, diagnosis and coding, both between and 
within countries is necessary. Furthermore, appropriate analyses of comparability both 
between and within countries is needed on all these aspects at regular intervals. Care 
must be then taken to ensure the appropriate certification and coding of multiple causes 
of deaths, e.g. diabetes and arthrosclerosis.  
 
Since 1994, Eurostat has been collecting regional mortality statistics from member 
states for a total of 65 individual or groups of causes of death.  This data cover several 
of the conditions that have been considered as ‘avoidable’ such as selected treatable 
cancers, ischaemic heart disease and cerebrovascular disease (Appendix 1). However, 
much of the Eurostat mortality data set is not sufficiently disaggregated to allow for 
detailed analysis of ‘avoidable’ mortality. Thus, Eurostat data will not allow separate 
monitoring of conditions such as Hodgkin’s disease (C81), appendicitis (K35-38), 
epilepsy (G40-G41), or medical errors resulting in patient death (Y60-69, Y83-84). If 
‘avoidable’ mortality is to be monitored at European level drawing on Eurostat data , it 
will be necessary for Eurostat to collect mortality data that are sufficiently 
disaggregated." 
 
Key recommendations for policy and action 
 
When using ‘avoidable’ mortality as an indicator of health system performance the 
following key recommendations should be considered: 
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• ‘Avoidable’ mortality is intended to point towards weaknesses or failures of the 
health system which require further investigation and not as an absolute measure 
of health care quality. 
• The measure of ‘avoidable’ mortality has a number of limitations which should be 
thoroughly considered by stakeholders if the indicator is to be routinely utilized as 
an indicator of the effectiveness of health services.  
• Conditions to be monitored will depend on the definition and scope of health 
services which are to be evaluated and by whom. The “AMIEHS” project is aiming 
to develop an agreed definition of ‘avoidable’ mortality for Europe and to derive a 
set of validated ‘avoidable’ mortality-based indicators which can be used in 
routine surveillance systems across European countries. 
• It is fundamental to identify interventions at each level of the health system for 
indicators of ‘avoidable’ mortality to ensure action. Designing an indicator to 
measure health system performance and collecting information without an 
appropriate follow up is futile. This process is supported by the “AMIEHS” project 
which will develop validated and agreed indicators that will describe the 
intervention/s and/or polices that have contributed to falling mortality from a 
given condition considered ‘avoidable’.  
• Once aggregate analysis of ‘avoidable’ mortality has been carried out, in depth 
systematic investigation of the underlying reasons for observed trends should 
follow according to existing and sound methodologies. In depth analysis of local 
and central level policies will be required, as well as an excellent understanding of 
how services targeted at the selected condition are being delivered and 
coordinated, starting from prevention, through diagnosis and treatment and 
management of the disease.  
• A suitable monitoring system is required to determine the effectiveness of any 
intervention. Then ‘avoidable’ mortality indicators have again to be monitored to 
see whether expected reductions in mortality rates have materialized as a result 
of the actions taken.  
• Detailed regional and national level data on deaths by ICD codes should be made 
available by Eurostat to allow for cross-country analysis at the European level. 
• At the same time, steps should be taken towards standardizing diagnostic 
patterns, death certification, coding (e.g. multiple causes of deaths) and reporting 
procedures.  
 
Overall, based on the trends in ‘avoidable’ deaths countries should be encouraged to 
actively take steps towards reducing mortality rates by improving the timeliness and 
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effectiveness of medical services.  At the same time, other measures both at the 
population and individual level should be monitored to provide a comprehensive 
understanding of health outcomes and performance of the health system in the country. 
As Charlton and colleagues (1983) noted, “it would be incorrect to judge the health 
services performance of health authorities solely on the basis of reported ‘avoidable’ 
mortality, since these indicators are intended merely to provide warning signals of 
possible shortcomings in health-care delivery”.  
 
 
 
Appendix 1 
 
Eurostat list of conditions and their use in some lists of ‘avoidable’ deaths 
Eurostat List of Causes of death ICD 10 EC/ 
Holland 
Nolte 
& 
McKee
Infectious and parasitic diseases  
Tuberculosis  
Meningococcal infection  
AIDS (HIV-disease)  
Viral hepatitis 
Neoplasms  
Malignant neoplasms  
Malignant neoplasm of lip, oral cavity, pharynx  
Malignant neoplasm of oesophagus  
Malignant neoplasm of stomach  
Malignant neoplasm of colon  
Malignant neoplasm of rectum and anus  
Malignant neoplasm liver and the intrahepatic 
bile ducts  
Malignant neoplasm of pancreas  
Malignant neoplasm of larynx and 
trachea/bronchus/lung  
Malignant melanoma of skin  
Malignant neoplasm of breast  
Malignant neoplasm of cervix uteri  
Malignant neoplasm of other parts of uterus 
Malignant neoplasm of ovary  
Malignant neoplasm of prostate  
Malignant neoplasm of kidney 
Malignant neoplasm of bladder  
Malignant neoplasm of lymphatic/haematopoietic 
tissue  
Dis. of the blood(-forming organs), 
immunological disorders  
Endocrine, nutritional and metabolic diseases  
A00-B99 
A15-A19,B90 
A39 
B20-B24 
B15-B19 
C00-D4 
C00-C97 
C00-C14 
C15 
C16 
C18 
C19-C21 
C22 
C25  
C32-C34 
C43 
C50 
C53 
C54-C55 
C56 
C61 
C64 
C67  
C81-C96 
D50-D89 
E00-E90 
E10-E14 
F00-F99 
F10 
F11-F16,F18-F19 
 
X 
 
 
 
 
 
 
 
 
 
 
 
 
 
X 
X 
X 
X 
 
 
 
 
 
 
 
 
 
 
 
 
X 
 
 
 
 
 
 
 
 
X 
X 
 
 
 
X 
X 
X 
X 
 
 
 
 
 
 
 
X 
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Eurostat List of Causes of death ICD 10 EC/ 
Holland 
Nolte 
& 
McKee
Diabetes mellitus  
Mental and behavioural disorders  
Alcoholic abuse (including alcoholic psychosis)  
Drug dependence, toxicomania  
Diseases of the nervous system and the sense 
organs  
Meningitis (other than 03)  
Diseases of the circulatory system  
Ischaemic heart diseases  
Other heart diseases  
Cerebrovascular diseases 
Diseases of the respiratory system  
Influenza  
Pneumonia  
Chronic lower respiratory diseases  
Asthma  
Diseases of the digestive system  
Ulcer of stomach, duodenum and jejunum  
Chronic liver disease  
Diseases of the skin and subcutaneous tissue  
Diseases of the musculoskeletal 
system/connective tissue Rheumatoid arthritis 
and osteoarthrosis  
Diseases of the genitourinary system  
Diseases of kidney and ureter  
Complications of pregnancy, childbirth and 
puerperium  
Certain conditions originating in the perinatal 
period  
Congenital malformations and chromosomal 
abnormalities  
Congenital malformations of the nervous system 
Congenital malformations of the circulatory 
system  
Symptoms, signs, abnormal findings, ill-defined 
causes  
Sudden infant death syndrome  
Unknown and unspecified causes 
External causes of injury and poisoning  
Accidents  
Transport accidents  
Accidental falls  
Accidental poisoning  
Suicide and intentional self-harm  
Homicide, assault  
Events of undetermined intent 
G00-H95 
G00-G03 
I00-I99 
I20-I25 
I30-I33,I39-I52 
I60-I69 
J00-J99 
J10-J11 
J12-J18 
J40-J47 
J45-J46 
K00-K93 
K25-K28 
K70, K73-K74 
L00-L99 
M00-M99 
M05-M06,M15-
M19 
N00-N99 
N00-N29 
O00-O99 
P00-P96 
Q00-Q99 
Q00-Q07 
Q20-Q28 
R00-R99 
R95 
R96-R99 
V01-Y89 
V01-X59 
V01-V99 
W00-W19 
X40-X49 
X60-X84 
X85-Y09 
Y10-Y34 
A00-Y89 
 
 
 
X 
 
X 
X 
X 
X 
 
X 
 
 
 
 
 
 
 
 
X 
 
 
 
X 
 
 
 
 
 
 
 
X 
 
X 
X 
X 
X 
 
 
 
 
 
 
 
 
 
 
X 
 
 
 
X 
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Eurostat List of Causes of death ICD 10 EC/ 
Holland 
Nolte 
& 
McKee
TOTAL  All causes of death  
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